[News-releases] Top Nuclear Chemist Joins TRIUMF from the United States

Tim Meyer tmeyer at triumf.ca
Tue Aug 4 08:00:29 PDT 2009

News Release | For Immediate Release | August 04, 2009

Paul Schaffer joins world-leading physics research laboratory

(Vancouver, BC) -- Dr. Paul Schaffer has joined TRIUMF, Canada’s national
laboratory for particle and nuclear physics, as Deputy Head of the Nuclear
Medicine Division. Dr. Schaffer comes to TRIUMF with expertise in nuclear
medicine imaging and therapy and was most recently lead scientist for
organic radiochemistry at a global medical research firm in the U.S.

"We're thrilled that Dr. Schaffer has joined our team of leading researchers
and scientists," said Dr. Nigel Lockyer, TRIUMF Director. "His extensive
knowledge and experience in nuclear medicine and radiochemistry (the field
of medical isotopes) will continue to keep TRIUMF at the forefront of
innovation. It's another example of TRIUMF's ability to attract the world's
best scientists to conduct research here in Canada."

Dr. Schaffer received his Ph.D. in chemistry from McMaster University in
2003 and is recognized as a technical leader for multiple efforts related to
radiopharmaceutical development.  He has worked extensively with medical
isotopes such as Technetium-99m and Fluorine-18.  At TRIUMF, he will be
responsible for managing the new research and development component of the
Nuclear Medicine Division as TRIUMF pursues a global-leadership position in
the field as part of its five-year plan.  The position manages a research
program aimed at exploiting the science and technology capabilities at
TRIUMF with an emphasis on the development and characterization of new

"I'm pleased to be coming home to Canada to join TRIUMF at one of the most
pivotal times in the industry," says Dr. Schaffer. "TRIUMF is a
long-standing Canadian research institution with world-leading science and
technology and I'm excited to be part of the future of this laboratory."

The announcement of the addition of Dr. Schaffer follows in the wake of
TRIUMF's participation in several international activities, including the
inaugural Japan/Canada accelerator symposium in July.  The symposium, held
in Tokyo, showcased Canadian and Japanese accelerator research and discussed
collaborative partnerships by the two countries.  In June, TRIUMF's
high-profile $6.3-million partnership with the Variable Energy Cyclotron
Centre (VECC) from Kolkata, India took effect and is spurring developments
in the study of materials and nuclei, cancer diagnosis, and medical‐isotope

The fundamental science conducted at TRIUMF is the foundation for
discoveries that have enhanced the health and quality of life of millions of
Canadians. By employing this science, TRIUMF is able to seed new high‐tech
companies, create new biologically‐specific medications, enable the
development of new materials, and advance computer technology.


Timothy I. Meyer, Ph.D.
Head, Strategic Planning & Communications
4004 Wesbrook Mall
Vancouver, BC V6T 2A3 CANADA
Tel: 604-222-7674
Fax: 604-222-3791
Cell: 650-464-8955
E-mail: tmeyer at triumf.ca

-------------- next part --------------
A non-text attachment was scrubbed...
Name: PR-04-Aug-2009-PaulSchaffer-V3.pdf
Type: application/pdf
Size: 121083 bytes
Desc: not available
Url : http://lists.triumf.ca/pipermail/news-releases/attachments/20090804/4b469443/PR-04-Aug-2009-PaulSchaffer-V3-0001.pdf

More information about the News-releases mailing list